ExpertiseUpdated on 14 April 2026
Due Diligence Support for Investors
Stephanie Jones MBChB MRCP MRCGP BClinSci DFSRH FFPM
Chief Medical Officer at Pharmora
Macclesfield, United Kingdom
About
Quick Review:
We can perform a short review of a potential asset to identify key red flags and help you decide whether this is an opportunity worth investing in further. Results are communicated in an online meeting.
Full Report:
If you are interested in an asset we can interrogate the data room, propose questions for the innovator, and determine the subsequent path to market. We can compare the asset to the current standard of care across different markets, exploring the potential market opportunity. The full report includes the competitor environment, therapy area context and a complete breakdown of the data provided on the asset, along with an Executive Summary. Top level findings can be communicated in a short call along with proposed questions for the innovator. We can help interpret the responses in further calls, and finalise the report according to your needs.
Field
- Biotech, Pharma and Cosmetics
- Healthcare
Organisation
Similar opportunities
Expertise
Investment Milestone Preparation Support for Innovators
- Healthcare
- Biotech, Pharma and Cosmetics
Stephanie Jones MBChB MRCP MRCGP BClinSci DFSRH FFPM
Chief Medical Officer at Pharmora
Macclesfield, United Kingdom
Expertise
EU project preparation and EU project management
Monika KORDIĆ
CEO at CORDION Ltd
Zagreb, Croatia
Expertise
Angela Ryan MPSI
Innosuisse Coach at MCE Mangement Centre Europe/Ryan Health First/Innosuisse Coach
Zurich 8008, Switzerland